Patent details
EP2379069 Title: DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
Basic Information
- Publication number:
- EP2379069
- PCT Application Number:
- PCT/EP/2009/067618
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP097935464
- PCT Publication Number:
- WO/2010/072703
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
- French Title of Invention:
- POSOLOGIE D'UN AGONISTE DU RÉCEPTEUR S1P
- German Title of Invention:
- DOSIERUNGSPLAN EINES S1P-REZEPTORAGONISTEN
- SPC Number:
-
LUC00160
Dates
- Filing date:
- 21/12/2009
- Grant date:
- 04/03/2015
- EP Publication Date:
- 04/03/2015
- PCT Publication Date:
- 01/07/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/10/2011
- EP B1 Publication Date:
- 04/03/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/12/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/12/2009
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- LEGANGNEUX Eric
- Address:
- Switzerland (CH)
Priority
1
- Priority Number:
- 139673 P
- Priority Date:
- 22/12/2008
- Priority Country:
- United States (US)
2
- Priority Number:
- 09167209
- Priority Date:
- 04/08/2009
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 31/192;
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 246 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/12/2024
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 230 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|